Loading...
Loading...
shares reached a new 52-week high of $27.62 after
AbbVie Inc.ABBV, in cooperation with Neurocrine Biosciences, announced positive top-line results from Phase 3 study of investigational medicine elagolix.
Impax Laboratories Inc.IPXL shares touched a new 52-week high of $35 after the company reported the FDA approval of RYTARY ER-capsules for the treatment of parkinson's disease.
Macy's, Inc.M shares touched a new 52-week high of $67.96. Macy's PEG ratio is 1.19.
Constellation Brands Inc. STZ shares climbed 4.76% to reach a new 52-week high of $107.96 after the company reported upbeat earnings for the fiscal third quarter and raised its forecast for the full year.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsIntraday UpdateMarketsMovers52 Week Highs52-Week HighsBiotechnologyConsumer DiscretionaryDepartment StoresHealth Care
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in